We are live on
!
Find out more
ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
1-Year Est. Return
7.38%
This Fund
S&P 500
This Quarter
Est. Return
+11.35%
1 Year Est. Return
+7.38%
3 Year Est. Return
+18.38%
5 Year Est. Return
+100.61%
10 Year Est. Return
–
AUM
$303M
AUM Growth
+$47.8M
(+19%)
Cap. Flow
+$22.2M
Cap. Flow
% of AUM
7.34%
Top 10 Holdings %
Top 10 Hldgs %
34.65%
Holding
115
New
28
Increased
31
Reduced
37
Closed
19
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Globus Medical
GMED
|
+$9.42M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$5.8M |
| 3 |
Enanta Pharmaceuticals
ENTA
|
+$5.1M |
| 4 |
STJ
St Jude Medical
STJ
|
+$4.11M |
| 5 |
Baxter International
BAX
|
+$4.05M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Encompass Health
EHC
|
+$7.11M |
| 2 |
Universal Health Services
UHS
|
+$5.84M |
| 3 |
Quest Diagnostics
DGX
|
+$5.57M |
| 4 |
Community Health Systems
CYH
|
+$4.33M |
| 5 |
Elevance Health
ELV
|
+$4.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 87.89% |
| 2 | Financials | 0.91% |
| 3 | Technology | 0.66% |
| 4 | Consumer Staples | 0.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Globus Medical
GMED
$10.7B
| $15.1M | 4.98% |
596,853
+386,553
| +184% | +$9.42M |
|
|
AGN
2
DELISTED
Allergan plc
AGN
| $14.7M | 4.84% |
49,266
+9,519
| +24% | +$2.71M |
|
3
Thermo Fisher Scientific
TMO
$213B
| $14M | 4.63% |
104,250
-16,700
| -14% | -$2.15M |
|
4
Becton Dickinson
BDX
$45.6B
| $13.3M | 4.4% |
94,977
+3,485
| +4% | +$488K |
|
5
Teva Pharmaceuticals
TEVA
$40.8B
| $11.2M | 3.69% |
179,500
+46,600
| +35% | +$2.71M |
|
6
Medtronic
MDT
$109B
| $7.72M | 2.55% |
98,962
-5,238
| -5% | -$397K |
|
|
BCR
7
DELISTED
CR Bard Inc.
BCR
| $7.43M | 2.45% |
44,399
+20,700
| +87% | +$3.55M |
|
8
Labcorp
LH
$25B
| $7.43M | 2.45% |
68,550
-16,063
| -19% | -$1.65M |
|
9
UnitedHealth
UNH
$376B
| $7.05M | 2.33% |
59,600
+23,500
| +65% | +$2.61M |
|
|
STJ
10
DELISTED
St Jude Medical
STJ
| $7.03M | 2.32% |
107,531
+61,800
| +135% | +$4.11M |
|
|
11
Elevance Health
ELV
$81.5B
| $6.71M | 2.22% |
43,475
-29,660
| -41% | -$4.22M |
|
|
AMSG
12
DELISTED
Amsurg Corp
AMSG
| $6.71M | 2.22% |
109,100
+64,900
| +147% | +$3.75M |
|
13
McKesson
MCK
$100B
| $6.46M | 2.13% |
28,535
-4,605
| -14% | -$1.02M |
|
14
Novartis
NVS
$297B
| $6.07M | 2.01% |
68,746
-10,713
| -13% | -$950K |
|
|
ESRX
15
DELISTED
Express Scripts Holding Company
ESRX
| $6M | 1.98% |
+69,200
| New | +$5.8M |
|
|
ASPX
16
DELISTED
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
| $5.94M | 1.96% |
59,250
+5,300
| +10% | +$353K |
|
|
HOLX
17
DELISTED
Hologic
HOLX
| $5.76M | 1.9% |
174,540
-54,000
| -24% | -$1.66M |
|
18
Teleflex
TFX
$6.05B
| $5.38M | 1.78% |
44,500
+33,300
| +297% | +$3.85M |
|
|
WBA
19
DELISTED
Walgreens Boots Alliance
WBA
| $4.64M | 1.53% |
54,800
+36,600
| +201% | +$2.91M |
|
20
Bausch Health
BHC
$2.58B
| $4.37M | 1.44% |
22,000
+2,800
| +15% | +$497K |
|
|
21
Community Health Systems
CYH
$393M
| $4.33M | 1.43% |
100,128
-104,665
| -51% | -$4.33M |
|
22
Boston Scientific
BSX
$69.5B
| $4.32M | 1.43% |
243,200
+29,900
| +14% | +$473K |
|
23
Cardinal Health
CAH
$53.9B
| $4.22M | 1.4% |
46,800
-26,000
| -36% | -$2.24M |
|
|
24
Enanta Pharmaceuticals
ENTA
$366M
| $4.01M | 1.33% |
+131,100
| New | +$5.1M |
|
|
25
Baxter International
BAX
$13.5B
| $3.97M | 1.31% |
+106,778
| New | +$4.05M |
|
Similar funds
VAFP
CA
SCM
FWM
TOPU
CCMU
TGI
HSCU
Endurant Capital Management's Q1 2015 Portfolio in Review
As of Q1 2015, Endurant Capital Management held 115 positions worth $303M, up 19% from $255M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Endurant Capital Management deployed $22.2M of net new capital in Q1 2015, opening 28 new positions and adding to 31 existing holdings. Its largest new stake was Express Scripts Holding Company: 69,200 shares worth $6M.
By sector, the portfolio is most concentrated in Healthcare at 88% of assets, up from 86% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Encompass Health, an estimated $7.11M trimmed.
- Endurant Capital Management's largest Q1 2015 buy was Express Scripts Holding Company: 69,200 shares worth $6M.
- Endurant Capital Management added most to Globus Medical in Q1 2015, an estimated $9.42M increase.
- Endurant Capital Management's biggest Q1 2015 reduction was Encompass Health, cutting an estimated $7.11M.
- Endurant Capital Management fully exited Quest Diagnostics in Q1 2015, selling an estimated $5.57M.
- Endurant Capital Management's ten largest holdings make up 35% of its $303M portfolio in Q1 2015.
- Endurant Capital Management opened 28 new positions and closed 19 in Q1 2015.
- Endurant Capital Management's portfolio value rose 19% quarter-over-quarter to $303M.
Based on Endurant Capital Management's 13F filing for Q1 2015, filed 15 May 2015.